![]() |
市場調查報告書
商品編碼
2102343
天然助眠補充品市場:預測至2034年-按產品類型、成分類型、劑型、通路、最終用戶和地區分類的全球分析Natural Sleep Aid Supplements Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Dosage Form, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球天然助眠補充劑市場預計將在 2026 年達到 60 億美元,並在預測期內以 13.7% 的複合年成長率成長,到 2034 年達到 130 億美元。
天然助眠劑是一種膳食補充劑,其配方包含植物萃取物、胺基酸、礦物質和維生素,透過非藥物機制促進入睡、延長睡眠時間和提高睡眠品質。這些補充劑通常含有褪黑素、纈草根、睡茄、洋甘菊、L-茶氨酸和鎂等成分,這些成分能夠與人體的晝夜節律和GABA能神經傳遞路徑相互作用。為了滿足不同消費者的偏好和吸收需求,這些產品有多種劑型可供選擇,包括片劑、膠囊、軟糖、粉末、滴劑和軟膠囊。天然助眠劑的生產符合膳食補充劑法規,強調萃取物濃度標準化、第三方純度檢測和潔淨標示。它們為尋求處方安眠藥替代方案的消費者提供,幫助他們應對偶發性失眠、時差反應和壓力引起的睡眠障礙。
睡眠障礙盛行率增加
全球失眠、睡眠呼吸中止症和晝夜節律紊亂的發病率不斷上升,導致各年齡層對天然助眠產品的需求持續增加。現代生活方式因素,例如過度使用電子螢幕、不規則的工作時間和日益成長的壓力水平,都導致了睡眠品質的普遍下降。世界衛生組織(WHO)已將睡眠不足列為公共衛生優先事項,並正在提高消費者對長期睡眠不足危害的認知。醫療保健專業人員擴大推薦天然助眠療法作為第一線治療方案,而非處方藥物。隨著全球人口老化,睡眠障礙患者的比例相對增加,這擴大了天然保健品所提供的溫和、無成癮性的睡眠解決方案的潛在市場。
對有效性的認知存在差距
消費者對天然助眠產品與處方藥相比的有效性持懷疑態度,這是他們嘗試使用和重複購買的主要障礙。纈草根和洋甘菊等植物成分的個體反應各不相同,導致使用者體驗不一致,削弱了口碑建議的效果。不同品牌缺乏標準化的劑量方案,令消費者感到困惑,並降低了對產品功效的信心。許多天然助眠成分的臨床證據僅限於調查方法上有缺陷的小規模研究。安慰劑效應導致消費者期望過高,而這些期望無法得到一致的滿足,導致使用一個月內停用率很高。
訂閱式健康模式
面向消費者的訂閱平台興起,為天然助眠補充劑品牌提供了一個突破性的機遇,使其能夠建立持續的收入來源並加深與客戶的關係。將個人化睡眠評估工具與訂閱服務結合,能夠根據個人睡眠模式和偏好,提供數據驅動的產品推薦。自動補貨模式降低了購買門檻,並提高了客戶終身價值 (CLV)。提供包含睡眠補充劑和鎂、舒緩壓力配方以及睡眠衛生配件等輔助產品的套裝,可以提高平均訂單價值 (AOV)。訂閱模式有助於持續提升消費者的睡眠健康知識,同時產生可預測的收入,從而支持持續的行銷投入和產品創新。
與處方藥的競爭
製藥業正在研發新一代助眠藥物,這些藥物具有更高的安全性和更快的起效速度,與天然助眠補充劑直接競爭。針對Orexin受體和褪黑素受體促效劑的新型配方,與傳統苯二氮平類藥物相比,副作用較少,且臨床療效已被證實。醫療報銷機制傾向於處方藥,這使得醫生更有經濟獎勵推薦藥物治療而非營養補充劑。新型助眠藥物的法規核准流程不斷加快,縮短了從臨床研發到上市的時間。製藥公司的行銷預算遠遠超越天然補充劑品牌,使其在醫療保健管道中擁有壓倒性的影響力。
新冠疫情給數百萬消費者帶來了焦慮、孤獨和日常生活的紊亂,導致全球睡眠障礙病例顯著增加。這種被稱為「新冠失眠」的現象,使得消費者透過電商和零售通路對天然助眠產品的需求空前高漲。供應鏈的限制一度導致褪黑素和睡茄等關鍵成分的供應不足。疫情過後,人們對睡眠作為免疫健康和整體健康基石的認知不斷提高,使得此類產品的需求持續旺盛。此外,遠距辦公的普及也讓消費者更靈活地調整睡眠時間。
在預測期內,褪黑素補充劑細分市場預計將佔據最大的市場佔有率。
預計在預測期內,褪黑素補充劑將佔據最大的市場佔有率,這主要得益於褪黑素在調節晝夜節律方面作用的廣泛臨床檢驗以及消費者對該成分的高度認知。憑藉數十年的科學研究和主要市場的監管批准,褪黑素補充劑已被廣泛接受為安全且無成癮性的處方安眠藥替代品。此成分有多種劑型可供選擇,包括片劑、軟糖和滴劑,能夠滿足不同年齡層消費者的偏好和需求。各大零售商都會醒目地展示褪黑素產品,確保其高知名度和易得性。兒童配方的推出也吸引了更多尋求更溫和兒童睡眠解決方案的家長加入目標市場。
預計在預測期內,睡茄細分市場將錄得最高的複合年成長率。
在預測期內,睡茄細分市場預計將呈現最高的成長率,這主要得益於消費者對適應原草藥興趣的激增,以及該成分獨特的功效組合:緩解壓力和改善睡眠品質。睡茄憑藉著健康社群和社群媒體上的意見領袖的推薦而備受關注,這些推薦強調了其傳統的阿育吠陀淵源和新興的臨床證據。該成分正獲得注重整體健康的消費者的青睞,因為它能夠解決壓力相關睡眠障礙的根本原因,而不僅僅是緩解症狀。標準化的根萃取配方,並檢驗含有瓦納內酯,提高了產品的穩定性,增強了消費者的信心。膳食補充劑品牌與阿育吠陀專家之間的合作,正在將專家推薦管道拓展到傳統醫療機構之外。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於消費者對睡眠健康的高認知度以及營養補充品零售體系的成熟。美國憑藉其強大的分銷網路(涵蓋藥局、保健食品店和電商平台)引領市場。 Nature's Bounty Co.、Church & Dwight Co., Inc. 和 OLLY PBC 等領先企業擁有豐富的產品系列和持續的行銷投入。該地區人口老化和職場壓力大,推動了對天然睡眠改善方案的持續需求。此外,美國食品藥物管理局 (FDA) 對褪黑素和草藥補充劑安全性的監管細則也增強了消費者的信心。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、印度和東南亞市場可支配收入的成長以及人們對睡眠健康意識的提高。該地區傳統醫學長期以來一直使用草藥助眠,這為天然保健品的廣泛應用奠定了文化基礎。快速的都市化和不斷變化的工作模式正在推高年輕一代睡眠障礙的盛行率。政府所推行的預防醫學政策正在創造有利的政策環境。此外,電子商務和D2C(直接面對消費者)品牌的擴張,使得以往無法透過傳統零售通路獲得的高階睡眠保健品更容易取得。
According to Stratistics MRC, the Global Natural Sleep Aid Supplements Market is accounted for $6.0 billion in 2026 and is expected to reach $13.0 billion by 2034 growing at a CAGR of 13.7% during the forecast period. Natural sleep aid supplements refer to dietary products formulated with botanical extracts, amino acids, minerals, and vitamins that promote sleep onset, duration, and quality through non-pharmaceutical mechanisms. These supplements typically incorporate ingredients such as melatonin, valerian root, ashwagandha, chamomile, L-theanine, and magnesium that interact with the body's circadian rhythm regulation and GABAergic neurotransmission pathways. The formulations are available in multiple delivery formats including tablets, capsules, gummies, powders, liquid drops, and softgels to accommodate diverse consumer preferences and absorption profiles. Natural sleep aid supplements are manufactured under dietary supplement regulations with emphasis on standardized extract potencies, third-party purity testing, and clean-label positioning. They serve consumers seeking alternatives to prescription sleep medications for managing occasional sleeplessness, jet lag, and stress-related sleep disruption.
Rising sleep disorder prevalence
The escalating global incidence of insomnia, sleep apnea, and circadian rhythm disorders is creating sustained demand for natural sleep aid supplements across all demographic segments. Modern lifestyle factors including excessive screen time, irregular work schedules, and heightened stress levels have contributed to widespread sleep quality deterioration. The World Health Organization has identified insufficient sleep as a public health priority, elevating consumer awareness about the long-term consequences of chronic sleep deprivation. Healthcare providers increasingly recommend natural sleep interventions as first-line treatments before prescribing pharmaceutical options. The aging global population experiences disproportionate sleep disruption, expanding the addressable market for gentle, non-habit-forming sleep solutions that natural supplements provide.
Efficacy perception gaps
Consumer skepticism regarding the effectiveness of natural sleep aids relative to prescription medications creates significant barriers to trial and repeat purchase behavior. The variability in individual response to botanical ingredients such as valerian root and chamomile leads to inconsistent user experiences that undermine word-of-mouth recommendations. The lack of standardized dosing protocols across brands confuses consumers and reduces confidence in product claims. Clinical evidence supporting many natural sleep ingredients remains limited to small-scale studies with methodological constraints. The placebo effect contributes to inflated expectations that are not consistently met, resulting in high product abandonment rates within the first month of use.
Subscription wellness models
The emergence of direct-to-consumer subscription platforms creates transformative opportunities for natural sleep aid supplement brands to build recurring revenue streams and deepen customer relationships. Personalized sleep assessment tools integrated with subscription services enable data-driven product recommendations tailored to individual sleep patterns and preferences. Automatic replenishment models reduce purchase friction and improve customer lifetime value metrics. Bundle offerings that combine sleep supplements with complementary products such as magnesium, stress relief formulas, and sleep hygiene accessories increase average order values. The subscription model facilitates continuous consumer education about sleep health while generating predictable revenue that supports sustained marketing investment and product innovation.
Prescription competition
The pharmaceutical industry's development of next-generation sleep medications with improved safety profiles and rapid onset characteristics poses direct competitive pressure on natural sleep aid supplements. New drug formulations targeting orexin receptors and melatonin receptor agonists offer clinically validated efficacy with reduced side effect profiles compared to traditional benzodiazepines. Healthcare reimbursement systems favor prescription medications, creating economic incentives for physicians to recommend pharmaceutical interventions over dietary supplements. The regulatory approval process for novel sleep drugs continues to accelerate, shortening the time between clinical development and commercial availability. Pharmaceutical marketing budgets dwarf those of natural supplement brands, enabling a dominant share of voice in healthcare provider channels.
The COVID-19 pandemic significantly increased sleep disruption globally as anxiety, isolation, and disrupted routines affected millions of consumers. This phenomenon, termed coronasomnia, drove unprecedented demand for natural sleep aid supplements through e-commerce and retail channels. Supply chain constraints temporarily limited the availability of key ingredients such as melatonin and ashwagandha. Post-pandemic, heightened awareness of sleep as a pillar of immune health and overall wellness has sustained elevated category demand. The normalization of remote work has also allowed consumers greater flexibility in sleep schedules.
The melatonin supplements segment is expected to be the largest during the forecast period
The melatonin supplements segment is expected to account for the largest market share during the forecast period, due to extensive clinical validation of melatonin's role in circadian rhythm regulation and widespread consumer familiarity with this ingredient. Melatonin supplements have achieved mainstream acceptance as a safe, non-habit-forming alternative to prescription sleep medications, supported by decades of scientific research and regulatory approval in major markets. The ingredient's versatility across multiple delivery formats, including tablets, gummies, and liquid drops, accommodates diverse consumer preferences and age groups. Major retailers stock melatonin products prominently, ensuring high visibility and accessibility. Pediatric formulations have expanded the addressable market to include parents seeking gentle sleep solutions for children.
The ashwagandha segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the ashwagandha segment is predicted to witness the highest growth rate, driven by surging consumer interest in adaptogenic herbs and the ingredient's dual positioning for stress reduction and sleep quality improvement. Ashwagandha has gained significant traction through social media wellness communities and influencer endorsements that highlight its traditional Ayurvedic roots and emerging clinical evidence. The ingredient addresses the root cause of stress-related sleep disruption rather than merely treating symptoms, appealing to holistic health consumers. Standardized root extract formulations with verified withanolide content have improved product consistency and consumer trust. Partnerships between supplement brands and Ayurvedic practitioners have expanded professional recommendation channels beyond conventional healthcare settings.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness of sleep health and the mature dietary supplement retail infrastructure. The United States leads with robust distribution through pharmacies, health food stores, and e-commerce platforms. Major companies, including Nature's Bounty Co., Church & Dwight Co., Inc., and OLLY PBC, maintain extensive product portfolios and marketing investments. The region's aging population and high-stress work culture drive sustained demand for natural sleep interventions. Regulatory clarity from the FDA regarding melatonin and herbal supplement safety supports consumer confidence.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rising disposable incomes and growing awareness of sleep health across China, India, and Southeast Asian markets. Traditional medicine systems in the region have long utilized herbal sleep remedies, providing a cultural foundation for natural supplement adoption. Rapid urbanization and changing work patterns have increased sleep disorder prevalence among younger demographics. Government health initiatives promoting preventive wellness create favorable policy environments. The expansion of e-commerce and direct-to-consumer brands has democratized access to premium sleep supplements previously unavailable through traditional retail channels.
Key players in the market
Some of the key players in Natural Sleep Aid Supplements Market include Nature's Bounty Co., Church & Dwight Co., Inc., Jamieson Wellness Inc., Nature's Way Products, LLC, OLLY PBC, Herbalife Ltd., Swisse Wellness Pty Ltd., Blackmores Limited, NOW Health Group, Inc., Life Extension, Thorne HealthTech, Inc., Nestle Health Science, Garden of Life LLC, Source Naturals, Inc., Solaray (Nutraceutical Corporation), Jarrow Formulas, Inc. and Pure Encapsulations, LLC.
In June 2026, Nature's Bounty Co. launched a time-release melatonin gummy formulation with magnesium and L-theanine for extended sleep support across major North American retail chains.
In April 2026, Thorne HealthTech, Inc. expanded its professional-grade sleep supplement line with a clinically tested amino acid complex designed for athletes and high-performance professionals.
In March 2026, Nestle Health Science secured European regulatory approval for its valerian root and chamomile sleep supplement, enabling market entry across EU member states through pharmacy channels.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.